Chourmouzios A. Arampatzis, MD

Effectiveness of the Sirolimus-Eluting Stent in the Treatment of Saphenous Vein Graft Disease

08/01/2008

Francesco Saia , MD, PhD;

Angela Hoye , MB, MRCP, MD, MBChB;

Pedro A. Lemos , MD;

Patrick W. Serruys , MD, PhD;

Chourmouzios A. Arampatzis , MD;

Muzaffer Degertekin , MD;

Sjoerd H. Hofma , MD;

Eugene P. McFadden , MB, MD;

Georgios Sianos , MD, PhD;

Pieter C. Smits , MD, PhD;

Kengo Tanabe , MD;

Willem J. van der Giessen , MD, PhD;

Pim J. de Feyter , MD, PhD;

Ron T. van Domburg , PhD;

ABSTRACT: The use of bare stents for the percutaneous intervention of saphenous vein bypass grafts (SVGs) is associated with a high subsequent rate of restenosis. To assess the impact of the sirolimus-eluting stent (SES), we studied 19...

ABSTRACT: The use of bare stents...

08/01/2008

Journal of Invasive Cardiology

Treatment of Coronary Artery Disease in Dialysis Patients with Sirolimus-eluting Stents: 1-year Clinical Follow-up of a Consecut

08/01/2008

Joost Daemen , MD, PhD;

Jiro Aoki , MD;

Angela Hoye , MB, MRCP, MD, MBChB;

Pedro A. Lemos , MD;

Patrick W. Serruys , MD, PhD;

Chourmouzios A. Arampatzis , MD;

Eugene P. McFadden , MB, MD;

In this preliminary series, sirolimus-eluting stent implantation appeared safe and effective for the treatment of dialysis patients with coronary artery disease. Dialysis patients are well known to be a high-risk population for cardiovascular...

In this preliminary series,...

08/01/2008

Journal of Invasive Cardiology